These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 14684238)

  • 41. Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 mg and 50 mg in migraine. Rizatriptan Protocol 046 Study Group.
    Goldstein J; Ryan R; Jiang K; Getson A; Norman B; Block GA; Lines C
    Headache; 1998; 38(10):737-47. PubMed ID: 11284462
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sumatriptan nasal spray in the acute treatment of migraine in adolescents and children.
    Callenbach PM; Pels LP; Mulder PG; Linssen WH; Gooskens RH; van der Zwan JL; Brouwer OF;
    Eur J Paediatr Neurol; 2007 Nov; 11(6):325-30. PubMed ID: 17428708
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral sumatriptan for acute migraine.
    McCrory DC; Gray RN
    Cochrane Database Syst Rev; 2003; (3):CD002915. PubMed ID: 12917936
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of the Pharmacokinetic Interaction of Ubrogepant Coadministered With Sumatriptan and of the Safety of Ubrogepant With Triptans.
    Jakate A; Boinpally R; Butler M; Lu K; McGeeney D; Periclou A
    Headache; 2020 Jul; 60(7):1340-1350. PubMed ID: 32573795
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of rizatriptan in the spectrum of headache.
    Allen C; Cady R; Lines C; McCarroll K
    Headache; 2001 Jun; 41(6):607-8. PubMed ID: 11437904
    [No Abstract]   [Full Text] [Related]  

  • 46. Spotlight on rizatriptan in migraine.
    Wellington K; Jarvis B
    CNS Drugs; 2002; 16(10):715-20. PubMed ID: 12269863
    [TBL] [Abstract][Full Text] [Related]  

  • 47. What matters is not the differences between triptans, but the differences between patients.
    Saper JR
    Arch Neurol; 2001 Sep; 58(9):1481-2. PubMed ID: 11559323
    [No Abstract]   [Full Text] [Related]  

  • 48. Spotlight on almotriptan in migraine.
    Keam SJ; Goa KL; Figgitt DP
    CNS Drugs; 2002; 16(7):501-7. PubMed ID: 12056924
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The pharmacokinetics and clinical efficacy of AVP-825: a potential advancement for acute treatment of migraine.
    Cady R
    Expert Opin Pharmacother; 2015; 16(13):2039-51. PubMed ID: 26255952
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sumatriptan: pharmacological basis and clinical results.
    Dahlöf CG
    Curr Med Res Opin; 2001; 17 Suppl 1():s35-45. PubMed ID: 12463276
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term open-label safety study of rizatriptan acute treatment in pediatric migraineurs.
    Hewitt DJ; Pearlman E; Hämäläinen M; Lewis D; Connor KM; Michelson D; Ceesay P; Assaid C; Bachman R; Harper Mozley L; Dupre N; Strickler N; Mahoney E; Lines C; Ho TW
    Headache; 2013 Jan; 53(1):104-117. PubMed ID: 23078588
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Meta-analysis examining the efficacy and safety of almotriptan in the acute treatment of migraine.
    Chen LC; Ashcroft DM
    Headache; 2007 Sep; 47(8):1169-77. PubMed ID: 17883521
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sumatriptan nasal spray for the acute treatment of migraine. Results of two clinical studies.
    Ryan R; Elkind A; Baker CC; Mullican W; DeBussey S; Asgharnejad M
    Neurology; 1997 Nov; 49(5):1225-30. PubMed ID: 9371898
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Triptans in the treatment of basilar migraine and migraine with prolonged aura.
    Klapper J; Mathew N; Nett R
    Headache; 2001; 41(10):981-4. PubMed ID: 11903526
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rizatriptan for acute migraine.
    Oldman AD; Smith LA; McQuay HJ; Moore RA
    Cochrane Database Syst Rev; 2001; (3):CD003221. PubMed ID: 11687054
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Triptans and migraine.
    Bateman DN
    Lancet; 2000 Mar; 355(9207):860-1. PubMed ID: 10752697
    [No Abstract]   [Full Text] [Related]  

  • 57. Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study.
    Dodick D; Brandes J; Elkind A; Mathew N; Rodichok L
    CNS Drugs; 2005; 19(2):125-36. PubMed ID: 15697326
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptan.
    Géraud G; Spierings EL; Keywood C
    Headache; 2002 Apr; 42 Suppl 2():S93-9. PubMed ID: 12028325
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of parecoxib, sumatriptan, and rizatriptan in the treatment of acute migraine attacks.
    Müller T; Lohse L
    Clin Neuropharmacol; 2011; 34(6):206-9. PubMed ID: 21996647
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sumatriptan. An updated review of its use in migraine.
    Perry CM; Markham A
    Drugs; 1998 Jun; 55(6):889-922. PubMed ID: 9617601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.